Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-20-030712

EVP, Head of R&D acquired 46,250 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Dupont Jakob EVP, Head of R&D 2020-05-14 Grant or award +46,250 46,250 D
Derivatives
Dupont Jakob EVP, Head of R&D 2020-05-14 Grant or award · Employee Stock Option (Right to Buy) +277,500 277,500 D
Loading xslF345X03/doc4.xml…